Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.
Saved in:
| Title: | Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma. |
|---|---|
| Authors: | Di Pietro A; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Au L; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Crock P; Bioinformatics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Thio N; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Bioinformatics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Pizzolla A; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Nguyen TN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Macdonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Chalmers H; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Zhu R; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Airaghi A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Molden-Hauer T; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Bacac M; Roche Innovation Center, Zurich, Switzerland., Schwalie P; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Schlenker R; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Mailer S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Barnes-Cullen K; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Winch K; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Chan J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Yeung GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Spain L; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Rao AD; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Gyorki DE; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Mackay LK; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Neeson PJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. paul.neeson@petermac.org.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. paul.neeson@petermac.org. |
| Source: | Nature communications [Nat Commun] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42277002 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Di+Pietro+A%22">Di Pietro A</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Au+L%22">Au L</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Crock+P%22">Crock P</searchLink>; Bioinformatics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Thio+N%22">Thio N</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Bioinformatics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Pizzolla+A%22">Pizzolla A</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+TN%22">Nguyen TN</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Macdonald+S%22">Macdonald S</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chalmers+H%22">Chalmers H</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Zhu+R%22">Zhu R</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Airaghi+A%22">Airaghi A</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Molden-Hauer+T%22">Molden-Hauer T</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Bacac+M%22">Bacac M</searchLink>; Roche Innovation Center, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwalie+P%22">Schwalie P</searchLink>; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schlenker+R%22">Schlenker R</searchLink>; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Levesque+MP%22">Levesque MP</searchLink>; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mailer+S%22">Mailer S</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Barnes-Cullen+K%22">Barnes-Cullen K</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Winch+K%22">Winch K</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chan+J%22">Chan J</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Yeung+GA%22">Yeung GA</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Spain+L%22">Spain L</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Rao+AD%22">Rao AD</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Sandhu+S%22">Sandhu S</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gyorki+DE%22">Gyorki DE</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22McArthur+GA%22">McArthur GA</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Melanoma Research Victoria, Melbourne, VIC, Australia.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Cancer Biology and Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mackay+LK%22">Mackay LK</searchLink>; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Neeson+PJ%22">Neeson PJ</searchLink>; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. paul.neeson@petermac.org.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. paul.neeson@petermac.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Jun 11. <i>Date of Electronic Publication: </i>2026 Jun 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42277002 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-026-74076-y Languages: – Code: eng Text: English Titles: – TitleFull: Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di Pietro A – PersonEntity: Name: NameFull: Au L – PersonEntity: Name: NameFull: Crock P – PersonEntity: Name: NameFull: Thio N – PersonEntity: Name: NameFull: Pizzolla A – PersonEntity: Name: NameFull: Nguyen TN – PersonEntity: Name: NameFull: Macdonald S – PersonEntity: Name: NameFull: Chalmers H – PersonEntity: Name: NameFull: Zhu R – PersonEntity: Name: NameFull: Airaghi A – PersonEntity: Name: NameFull: Molden-Hauer T – PersonEntity: Name: NameFull: Bacac M – PersonEntity: Name: NameFull: Schwalie P – PersonEntity: Name: NameFull: Schlenker R – PersonEntity: Name: NameFull: Levesque MP – PersonEntity: Name: NameFull: Mailer S – PersonEntity: Name: NameFull: Barnes-Cullen K – PersonEntity: Name: NameFull: Winch K – PersonEntity: Name: NameFull: Chan J – PersonEntity: Name: NameFull: Yeung GA – PersonEntity: Name: NameFull: Spain L – PersonEntity: Name: NameFull: Rao AD – PersonEntity: Name: NameFull: Sandhu S – PersonEntity: Name: NameFull: Gyorki DE – PersonEntity: Name: NameFull: McArthur GA – PersonEntity: Name: NameFull: Mackay LK – PersonEntity: Name: NameFull: Neeson PJ IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2026 Jun 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2041-1723 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |